Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Zebra 365 who wrote (4990)	1/25/1998 3:55:00 PM
From: LoLoLoLita	Respond to of 23519

Zebra, Thanks for your reply. I agree that if sildenafil does not allow healthy males to have prolonged intercourse and/or erection after ejaculation, then it may not be widely abused, and the DEA would then probably not take any action. But if it is truly lacking in those attributes as you suggest, doesn't that lead to questions of how effective it will be in cases of moderate and severe ED? My point is only to raise for discussion the premise that if Viagra really is the magical sex pill that's always eluded searchers (till now), then it will probably be abused, and ultimately scheduled as a controlled substance. But, if it's not that good a sex drug, then people with ED will still need MUSE and Caverject. Only time will tell how effective it is as a "aphrodisiac" as compared to placebo. But there is already one instance of theft at a clinical trials site, and two instances of FDA import detentions, as noted in my previous posts. If there are future increases in such incidents, fueled by media hype, then DEA action would be more likely. I don't see MUSE as a candidate for scheduling because of the need for urethral insertion, as well as the need to keep the product refrigerated, both of which make it less attractive than pills in the black market. David

To: Zebra 365 who wrote (4990)	1/25/1998 4:28:00 PM
From: Tunica Albuginea	Read Replies (1) \| Respond to of 23519

Zebra, I have an essay question for you: " Should Vivus investors be concerned of a possible Vivus stock price drop next week if and when it is proven by Bill Clinton that Erectile Dysfunction in middle age is significantly more rare ( ie fewer MUSE sales )than the alleged 20 mill + number we were looking at before? ( for this threat to become real it will be neccessary to prove today's ? NY Enquirer front page picture of Bill and Monica with the underneath caption " there are hundreds out there ! ". I apologize for the long title but sometimes things can get complicated in the ED field. TA